Mr. Jason Hein reports

TELESCOPE INNOVATIONS IS GRANTED A CANADIAN PATENT ON CHEMICAL SYNTHESIS ROUTE

Telescope Innovations Corp. has been granted a Canadian patent, through its wholly owned subsidiary, for a scalable manufacturing process to produce pharmaceutically relevant indole compounds. Telescope developed this process in response to globally rising demands for pharmaceutical-grade therapeutics such as psilocybin and other indole-based precursors, analogues and derivatives.

The patented chemical synthesis facilitates high-quality, scalable manufacturing because it reduces the number of synthetic steps than current methods, utilizes cost-effective and readily available starting materials, and leverages chemical manufacturing techniques that are already standard practice in the pharmaceutical industry.

"This patent highlights our ability to address key challenges in process chemistry and manufacturing," said Jason Hein, the company's chief executive officer. "Telescoping is actually a technical term for reducing the number of isolation and workup steps in a chemical synthesis -- hence our name. With this approach, we've patented a process that reduces manufacturing complexity and improves scalability for indole-based therapeutics."

Along with the synthetic route, Telescope also patented a set of new molecules that may become candidates for preclinical development. The discovery of both the synthetic route and new molecules was enabled by Telescope's unique suite of analytical and automation technologies, including the direct inject liquid chromatography (DILC) platform for quantitative, on-line reaction monitoring.

"The DILC system is a crucial enabling technology to understand and develop better chemical processes. It was instrumental in obtaining our first Canadian patent, and we're excited to continue deploying it across our research programs."

About Telescope Innovations Corp.

Telescope is a chemical technology company developing scalable manufacturing processes and tools for the pharmaceutical and chemical industry. The company builds and deploys new enabling technologies, including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency and data quality. The company's aim is to bring modern chemical technology solutions to meet the most serious challenges in health and sustainability.

We seek Safe Harbor.